妊娠期重度高血压治疗方案不依从性研究
本研究为回顾性队列研究,纳入2018年2月1日至2020年3月1日期间在3家医院分娩住院时出现持续性重度高血压的996例患者,评估与不依从机构治疗方案相关的因素。结果显示45%患者在60分钟内接受治疗,55%未接受;入院时血压升高、分娩前后持续性重度高血压及慢性高血压与及时治疗相关,而医院站点和孕周增加与不依从相关。
要点
- 持续性重度高血压定义为间隔15-60分钟两次收缩压≥160 mmHg和/或舒张压>110 mmHg。
- 996例中449例(45%)在60分钟内接受治疗,547例(55%)未接受。
- 医院站点(aOR 1.97)和孕周增加(aOR 1.14)与不依从治疗方案相关。
核心结论
- 多个因素与不依从持续性重度高血压的机构治疗方案相关,提供者偏倚可能影响治疗执行,认识这些风险因素或可改善抗高血压药物的及时给药。
研究设计与样本
- 回顾性队列研究,纳入2018年2月1日至2020年3月1日在整合健康系统内3家医院分娩住院期间出现持续性重度高血压的患者,共996例。
- 依从性定义为在第二次重度血压测量后1小时内接受抗高血压药物。
- 采用多变量逻辑回归评估与延迟治疗相关的因素,并调整潜在混杂因素;患者邮编链接至美国人口普查局美国社区调查的邻里数据以提取社会经济特征。
主要发现
- 996例患者中,449例(45%)在60分钟内接受治疗,547例(55%)未接受。
- 入院时血压升高但未达重度范围(aOR 0.55;95%CI 0.38-0.79)或达重度范围(aOR 0.25;95%CI 0.16-0.38)、分娩前后持续性重度高血压≥1小时(aOR 0.27;95%CI 0.27-0.45)及慢性高血压(aOR 0.58;95%CI 0.37-0.93)与及时治疗相关。
- 医院站点(aOR 1.97;95%CI 1.18-3.28)和孕周增加(aOR 1.14;95%CI 1.07-1.21)与不依从治疗方案相关。
- 亚组分析纳入344例(35%)入院时血压未升高的患者,显示白人种族、分娩后1小时内持续性重度高血压、孕周增加、体重指数、双胎妊娠、首选语言非英语或西班牙语及邻里失业率较高与不依从治疗方案相关。
关键数值与推荐
- 持续性重度高血压定义为间隔15-60分钟两次收缩压≥160 mmHg和/或舒张压>110 mmHg。
- 依从性定义为在第二次重度血压测量后1小时内接受抗高血压药物。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypertensive disorders of pregnancy are one of the leading causes of maternal mortality and severe morbidity. The American College of Obstetricians and Gynecologists recommends treatment of persistent severe hypertension because this has been shown to improve overall outcomes. Treatment remains inconsistent and may be influenced by patient-level sociodemographic and clinical characteristics. OBJECTIVE: This study aimed to identify which factors are associated with nonadherence to an institutional protocol for the treatment of severe hypertension in pregnancy. STUDY DESIGN: Retrospective cohort study of patients who had persistent severe hypertension (≥2 systolic blood pressures ≥160 mm Hg and/or diastolic blood pressures >110 mm Hg between 15 and 60 minutes apart) during their delivery hospitalization in 3 hospitals within an integrated health system from February 1, 2018 to March 1, 2020. Adherence to an institutional protocol was defined as receiving antihypertensive medication within 1 hour of a second severe blood pressure measurement. Demographic information, medical comorbidities, and delivery hospitalization characteristics were compared between women who received treatment based on institutional protocol and those who did not. Patient zone improvement plan codes were linked to neighborhood-level data from the US Census Bureau's American Community Survey to extract socioeconomic characteristics. A multivariable logistic regression was performed to evaluate factors associated with delayed treatment while adjusting for potential confounders. RESULTS: Of the 996 patients included, 449 (45%) received treatment within 60 minutes and 547 (55%) did not. Having an elevated, nonsevere range blood pressure (adjusted odds ratio, 0.55; 95% confidence interval, 0.38-0.79) or a severe range blood pressure (adjusted odds ratio, 0.25; 95% confidence interval, 0.16-0.38) on admission, persistent severe hypertension ≥1 hour before or after delivery (adjusted odds ratio, 0.27; 95% confidence interval, 0.27-0.45), and chronic hypertension (adjusted odds ratio, 0.58; 95% confidence interval, 0.37-0.93) were associated with timely treatment. Hospital site (adjusted odds ratio, 1.97; 95% confidence interval, 1.18-3.28) and increasing gestational age (adjusted odds ratio, 1.14; 95% confidence interval, 1.07-1.21) were associated with nonadherence to treatment protocol. A subanalysis evaluating treatment in 344 (35%) patients who had a nonelevated blood pressure on admission showed that White race, persistent severe hypertension within 1 hour of delivery, increasing gestational age, body mass index, twin gestation, preferred language other than English or Spanish, and a higher neighborhood unemployment rate were associated with nonadherence to treatment protocol. CONCLUSION: Several factors were associated with nonadherence to an institutional protocol for treatment of persistent severe hypertension. Provider bias may impact whether treatment is executed or not. Awareness of these risk factors may improve timely administration of antihypertensive medication in pregnant and postpartum patients.
引用
- Jeganathan S, Wetcher CS, White V, et al. Nonadherence to treatment protocol for severe hypertension in pregnancy. Am J Obstet Gynecol MFM. 2022. PMID: 35817395. doi:10.1016/j.ajogmf.2022.100688
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。